Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 20.85
-0.42 (-1.97%)
Nov 6, 2026, 10:25 AM CST
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 2.35 billion as of November 5, 2026. It is the 16,660th most valuable company in the world and the 4,496th biggest in China. Its market cap has decreased by 1.19% in one year.
Market Cap
2.35B
Enterprise Value
2.95B
Revenue
952.80M
Global Rank
Country Rank
#4,496 China
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 2.35B, a decrease of -53.92%. That is a compound annual growth rate of -12.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 2.35B | 17.13% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Goto Biopharm Group | 2.83B |
| Zhejiang Shouxiangu Pharmaceutical | 2.74B |
| Beijing Kawin Technology Share-Holding | 2.71B |
| Landfar Bio-medicine | 2.67B |
| Guangdong VTR Bio-Tech | 2.56B |
| Yantai Zhenghai Biotechnology | 2.52B |
| Shanghai Universal Biotech | 2.47B |
| Shenzhen Bioeasy Biotechnology | 2.37B |